Aesthetic Devices - Medical Devices Pipeline Assessment, 2019

GlobalData
265 Pages - GLDATA67083
$4,000.00

Summary

GlobalData's Medical Devices sector report, “Aesthetic Devices - Medical Devices Pipeline Assessment, 2019" provides an overview of Aesthetic Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Aesthetic Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Aesthetic Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Aesthetic Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry.

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Aesthetic Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date.



Companies Mentioned
Aeon Astron Corporation
Aesthetic Medical Device
Aesthetics Point Ltd.
Allergan Plc
Almirall Ltd
Ambicare Health Ltd
Apyx Medical Corp
Avita Medical Ltd
Bausch Health Companies Inc
Biosculpture Technology, Inc.
BioTime Inc
Bioxis Pharmaceuticals
BMG Pharma srl
Bmi Korea Co Ltd
Celltrix AB
CollPlant Holdings Ltd
Cutera Inc
Cynosure Inc
Cytrellis Biosystems Inc
Eclipse Aesthetics LLC
Elastagen Pty Ltd
Ellman International Inc
Emory University
Erchonia Corp
Eternity Healthcare Inc.
EternoGen Aesthetics LLC
Forticell Bioscience Inc
Fourth State Medicine Ltd
Genzyme Corp
ImpLite Ltd.
Innova Medical Design
Innovia LLC
IonMed Ltd.
Juvenis Ltd
Khorionyx SA
LifeCell Corp
LifeSprout Inc
Medifirst Solutions Inc
Medixsysteme
Medytox Inc
Merz Pharma GmbH & Co KgaA
Mesoestetic Pharma Group SL
Moma Therapeutics, Inc.
N8 Medical Inc
NanoVibronix Inc
Neosthetic, LLC
Northwestern University
Nu Skin International Inc.
Oligo Medic Inc
Oxtex Ltd
PB&B SA
PetVivo Holdings Inc
PhotoDerma SA
PhotoMedex Inc
PhotoSonix Medical, Inc.
Pinnacle Therapeutics
PolyNovo Biomaterials Pty Ltd
PS Advanced Engineering
Recros Medica Inc
Regen Lab SA
Regenscientific
Samyang Biopharmaceuticals Corp
SANUWAVE Health Inc
Sebacia Inc
Sebana Medical Ltd
Sekisui Medical Co Ltd
Serene Medical, Inc.
Shanghai Haohai Biological Technology Co Ltd
Shin Poong PharmCo Ltd
Sienna Biopharmaceuticals Inc
Sinclair Pharma PLC
Slender Medical Ltd.
Sofregen Medical Inc
Solta Medical Inc
Southern Illinois University Carbondale
Syneron Medical Ltd
TEI Biosciences Inc
University of California Irvine
University of California Santa Barbara
Zeltiq Aesthetics Inc
Zift Medical LLC

'

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Aesthetic Devices Overview
3 Products under Development
3.1 Aesthetic Devices - Pipeline Products by Stage of Development
3.2 Aesthetic Devices - Pipeline Products by Segment
3.3 Aesthetic Devices - Pipeline Products by Territory
3.4 Aesthetic Devices - Pipeline Products by Regulatory Path
3.5 Aesthetic Devices - Pipeline Products by Estimated Approval Date
3.6 Aesthetic Devices - Ongoing Clinical Trials
4 Aesthetic Devices - Pipeline Products under Development by Companies
4.1 Aesthetic Devices Companies - Pipeline Products by Stage of Development
4.2 Aesthetic Devices - Pipeline Products by Stage of Development
5 Aesthetic Devices Companies and Product Overview
5.1 Aeon Astron Corporation Company Overview
5.2 Aesthetic Medical Device Company Overview
5.3 Aesthetics Point Ltd. Company Overview
5.4 Allergan Plc Company Overview
5.5 Almirall Ltd Company Overview
5.6 Ambicare Health Ltd Company Overview
5.7 Apyx Medical Corp Company Overview
5.8 Avita Medical Ltd Company Overview
5.9 Bausch Health Companies Inc Company Overview
5.10 Biosculpture Technology, Inc. Company Overview
5.11 BioTime Inc Company Overview
5.12 Bioxis Pharmaceuticals Company Overview
5.13 BMG Pharma srl Company Overview
5.14 Bmi Korea Co Ltd Company Overview
5.15 Celltrix AB Company Overview
5.16 CollPlant Holdings Ltd Company Overview
5.17 Cutera Inc Company Overview
5.18 Cynosure Inc Company Overview
5.19 Cytrellis Biosystems Inc Company Overview
5.20 Eclipse Aesthetics LLC Company Overview
5.21 Elastagen Pty Ltd Company Overview
5.22 Ellman International Inc Company Overview
5.23 Emory University Company Overview
5.24 Erchonia Corp Company Overview
5.25 Eternity Healthcare Inc. Company Overview
5.26 EternoGen Aesthetics LLC Company Overview
5.27 Forticell Bioscience Inc Company Overview
5.28 Fourth State Medicine Ltd Company Overview
5.29 Genzyme Corp Company Overview
5.30 ImpLite Ltd. Company Overview
5.31 Innova Medical Design Company Overview
5.32 Innovia LLC Company Overview
5.33 IonMed Ltd. Company Overview
5.34 Juvenis Ltd Company Overview
5.35 Khorionyx SA Company Overview
5.36 LifeCell Corp Company Overview
5.37 LifeSprout Inc Company Overview
5.38 Medifirst Solutions Inc Company Overview
5.39 Medixsysteme Company Overview
5.40 Medytox Inc Company Overview
5.41 Merz Pharma GmbH & Co KgaA Company Overview
5.42 Mesoestetic Pharma Group SL Company Overview
5.43 Moma Therapeutics, Inc. Company Overview
5.44 N8 Medical Inc Company Overview
5.45 NanoVibronix Inc Company Overview
5.46 Neosthetic, LLC Company Overview
5.47 Northwestern University Company Overview
5.48 Nu Skin International Inc. Company Overview
5.49 Oligo Medic Inc Company Overview
5.50 Oxtex Ltd Company Overview
5.51 PB&B SA Company Overview
5.52 PetVivo Holdings Inc Company Overview
5.53 PhotoDerma SA Company Overview
5.54 PhotoMedex Inc Company Overview
5.55 PhotoSonix Medical, Inc. Company Overview
5.56 Pinnacle Therapeutics Company Overview
5.57 PolyNovo Biomaterials Pty Ltd Company Overview
5.58 PS Advanced Engineering Company Overview
5.59 Recros Medica Inc Company Overview
5.60 Regen Lab SA Company Overview
5.61 Regenscientific Company Overview
5.62 Samyang Biopharmaceuticals Corp Company Overview
5.63 SANUWAVE Health Inc Company Overview
5.64 Sebacia Inc Company Overview
5.65 Sebana Medical Ltd Company Overview
5.66 Sekisui Medical Co Ltd Company Overview
5.67 Serene Medical, Inc. Company Overview
5.68 Shanghai Haohai Biological Technology Co Ltd Company Overview
5.69 Shin Poong PharmCo Ltd Company Overview
5.70 Sienna Biopharmaceuticals Inc Company Overview
5.71 Sinclair Pharma PLC Company Overview
5.72 Slender Medical Ltd. Company Overview
5.73 Sofregen Medical Inc Company Overview
5.74 Solta Medical Inc Company Overview
5.75 Southern Illinois University Carbondale Company Overview
5.76 Syneron Medical Ltd Company Overview
5.77 TEI Biosciences Inc Company Overview
5.78 University of California Irvine Company Overview
5.79 University of California Santa Barbara Company Overview
5.80 Zeltiq Aesthetics Inc Company Overview
5.81 Zift Medical LLC Company Overview
6 Aesthetic Devices- Recent Developments
6.1 Jul 19, 2018: Suneva Medical promotes Patricia Altavilla to chief operating officer
6.2 Jul 19, 2018: Misonix appoints Gwen Watanabe as board director
6.3 Jul 16, 2018: Cutera Launches truSculpt iD, Personalized Body Sculpting: The Next Evolution
6.4 Jul 12, 2018: InMode Introduces Triton: The World’s First and Only Simultaneous Multi-Wavelength Hair Removal
6.5 Jul 09, 2018: Solsys Medical Appoints Dr. Arti Masturzo As Chief Medical Officer
6.6 Jul 05, 2018: Sinclair Pharma: Trading Update for the 6 months to 30 June 2018
6.7 Jul 02, 2018: Lumenis Unveils NuEra tight , Its High Power, Temperature-Controlled Top to Toe Radio Frequency Skin Laxity and Cellulite Treatment, at the 2018 Aesthetic Show
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

1.1 List of Tables
Table 1: Aesthetic Devices - Pipeline Products by Stage of Development
Table 2: Aesthetic Devices - Pipeline Products by Segment
Table 3: Aesthetic Devices - Pipeline Products by Territory
Table 4: Aesthetic Devices - Pipeline Products by Regulatory Path
Table 5: Aesthetic Devices - Pipeline Products by Estimated Approval Date
Table 6: Aesthetic Devices - Ongoing Clinical Trials
Table 7: Aesthetic Devices Companies - Pipeline Products by Stage of Development
Table 8: Aesthetic Devices - Pipeline Products by Stage of Development
Table 9: Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 10: BioDermal Filler - Product Status
Table 11: BioDermal Filler - Product Description
Table 12: Aesthetic Medical Device Pipeline Products & Ongoing Clinical Trials Overview
Table 13: Alluris - Product Status
Table 14: Alluris - Product Description
Table 15: Skinlumina - Product Status
Table 16: Skinlumina - Product Description
Table 17: Aesthetics Point Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Juvence Implant - Product Status
Table 19: Juvence Implant - Product Description
Table 20: Allergan Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 21: AAM SubQ Body Filler - Product Status
Table 22: AAM SubQ Body Filler - Product Description
Table 23: ADM Subdermal Body Filler - Product Status
Table 24: ADM Subdermal Body Filler - Product Description
Table 25: Botox - Masseter - Product Status
Table 26: Botox - Masseter - Product Description
Table 27: Botox - Platysma/Masseter - Product Status
Table 28: Botox - Platysma/Masseter - Product Description
Table 29: earFold - Product Status
Table 30: earFold - Product Description
Table 31: Eplica Silk - Product Status
Table 32: Eplica Silk - Product Description
Table 33: HA Threads - Product Status
Table 34: HA Threads - Product Description
Table 35: Juvederm - Decolletage - Product Status
Table 36: Juvederm - Decolletage - Product Description
Table 37: Juvederm - Hands - Product Status
Table 38: Juvederm - Hands - Product Description
Table 39: Juvederm - Neck Lines - Product Status
Table 40: Juvederm - Neck Lines - Product Description
Table 41: Juvederm RejuveCross - Deep Wrinkles - Product Status
Table 42: Juvederm RejuveCross - Deep Wrinkles - Product Description
Table 43: Juvederm RejuveCross - Etched Lines Wrinkles - Product Status
Table 44: Juvederm RejuveCross - Etched Lines Wrinkles - Product Description
Table 45: Juvederm RejuveCross Volumize - Cheek Augmentation - Product Status
Table 46: Juvederm RejuveCross Volumize - Cheek Augmentation - Product Description
Table 47: JUVEDERM Volbella - Tear Trough - Product Status
Table 48: JUVEDERM Volbella - Tear Trough - Product Description
Table 49: Juvederm Vollure XC - Product Status
Table 50: Juvederm Vollure XC - Product Description
Table 51: JUVEDERM VOLUMA - Nose - Product Status
Table 52: JUVEDERM VOLUMA - Nose - Product Description
Table 53: JUVEDERM Voluma - Temple - Product Status
Table 54: JUVEDERM Voluma - Temple - Product Description
Table 55: JUVEDERM Voluma Global - Malar Augmentation - Product Status
Table 56: JUVEDERM Voluma Global - Malar Augmentation - Product Description
Table 57: JUVEDERM Volux - Facial Volume - Product Status
Table 58: JUVEDERM Volux - Facial Volume - Product Description
Table 59: MicroCell - Breast Augmentation - Product Status
Table 60: MicroCell - Breast Augmentation - Product Description
Table 61: Phoenix - Breast Augmentation - Product Status
Table 62: Phoenix - Breast Augmentation - Product Description
Table 63: SeriGel - Product Status
Table 64: SeriGel - Product Description
Table 65: Skin Quattro Device - Product Status
Table 66: Skin Quattro Device - Product Description
Table 67: VYC-25L Hyaluronic Acid Injectable Gel - Product Status
Table 68: VYC-25L Hyaluronic Acid Injectable Gel - Product Description
Table 69: Allergan Plc - Ongoing Clinical Trials Overview
Table 70: Juvederm Vollure XC - LIPS: Prospective, Open-label Study to Evaluate the Effectiveness of Juvederm VOLIFT with Lidocaine for Lip Augmentation
Table 71: earFold - Long Term Prospective Uncontrolled Study of Earfold or the Treatment of Prominent Ears: FOLD
Table 72: Almirall Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 73: Hyaluronic Acid Facial Filler - Product Status
Table 74: Hyaluronic Acid Facial Filler - Product Description
Table 75: Ambicare Health Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 76: Ambulight Rejuvenate - Product Status
Table 77: Ambulight Rejuvenate - Product Description
Table 78: Apyx Medical Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 79: Renuvion - Dermal Resurfacing - Product Status
Table 80: Renuvion - Dermal Resurfacing - Product Description
Table 81: Apyx Medical Corp - Ongoing Clinical Trials Overview
Table 82: Renuvion - Dermal Resurfacing - A Prospective, Multicenter, Single Arm Clinical Study Evaluating the Use of J-Plasma for Dermal Resurfacing
Table 83: Avita Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 84: ReNovaCell - Aesthetics And Repigmentation - Product Status
Table 85: ReNovaCell - Aesthetics And Repigmentation - Product Description
Table 86: Avita Medical Ltd - Ongoing Clinical Trials Overview
Table 87: ReNovaCell - Aesthetics And Repigmentation - Autologous Cell Suspension Grafting Using ReNovacell in Non-segmental Vitiligo Patients: A Randomized Controlled Study
Table 88: Bausch Health Companies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 89: SOF - 010: Skin Resurfacing - Product Status
Table 90: SOF - 010: Skin Resurfacing - Product Description
Table 91: SOM - 010: Vascular Lesions - Product Status
Table 92: SOM - 010: Vascular Lesions - Product Description
Table 93: SOT - 010: Fine Lines & wrinkles - Product Status
Table 94: SOT - 010: Fine Lines & wrinkles - Product Description
Table 95: SOT - 011: Fine Lines & Wrinkles - Product Status
Table 96: SOT - 011: Fine Lines & Wrinkles - Product Description
Table 97: XUA - 001: Hair Removal - Product Status
Table 98: XUA - 001: Hair Removal - Product Description
Table 99: Biosculpture Technology, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 100: Airbrush Liposculptor IIE - Product Status
Table 101: Airbrush Liposculptor IIE - Product Description
Table 102: Airbrush Liposculptor IIIE - Product Status
Table 103: Airbrush Liposculptor IIIE - Product Description
Table 104: BioTime Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 105: Renevia - Product Status
Table 106: Renevia - Product Description

1.2 List of Figures
Figure 1: Aesthetic Devices - Pipeline Products by Stage of Development
Figure 2: Aesthetic Devices - Pipeline Products by Segment
Figure 3: Aesthetic Devices - Pipeline Products by Territory
Figure 4: Aesthetic Devices - Pipeline Products by Regulatory Path
Figure 5: Aesthetic Devices - Pipeline Products by Estimated Approval Date
Figure 6: Aesthetic Devices - Ongoing Clinical Trials

$4,000.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838